Tower Research Capital (TRC)’s Amrize Ltd AMRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.57K Buy
28
+13
+87% +$745 ﹤0.01% 4636
2025
Q4
$811 Sell
15
-1,663
-99% -$84.9K ﹤0.01% 4814
2025
Q3
$81.4K Buy
+1,678
New +$85.6K ﹤0.01% 2168

Other funds holding AMRZ

Tower Research Capital (TRC)'s AMRZ Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Amrize Ltd (AMRZ) stake by 87% in Q1 2026, buying an estimated $745 and bringing the position to 28 shares worth $1.57K. The position accounts for ﹤0.01% of the portfolio, ranked #4636.

Tower Research Capital (TRC) first reported a position in AMRZ in Q3 2025 and has held it in 3 quarters since. The position peaked at $81.4K in Q3 2025. 447 funds tracked by Wall St. Rank hold AMRZ as of Q1 2026.

  • Tower Research Capital (TRC) held 28 shares of Amrize Ltd worth $1.57K as of Q1 2026.
  • Tower Research Capital (TRC) bought 13 Amrize Ltd shares in Q1 2026, an estimated $745.
  • Amrize Ltd made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4636 holding.
  • Tower Research Capital (TRC) first reported a position in Amrize Ltd in Q3 2025 and has held it in 3 quarters since.
  • Tower Research Capital (TRC)'s Amrize Ltd position peaked at $81.4K in Q3 2025.
  • 447 funds tracked by Wall St. Rank held Amrize Ltd as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.